Considering that PCA patients in China are less likely to take part in early screenings and thus more likely to be diagnosed with later stages of the disease [14], introducing accessible and non-invasive diagnostic tools (including serum PSA test and TR-CDFI) that promote earlier diagnosis could likely bring more benefits, as demonstrated in an recent Italian literature [15]. Here, KLK3 is linked to posterior cortical atrophy.